Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34 | -19.0% | 6,270 | +1.6% | 0.00% | – |
Q2 2023 | $42 | +35.5% | 6,173 | -0.8% | 0.00% | – |
Q1 2023 | $31 | -74.2% | 6,225 | -74.7% | 0.00% | – |
Q4 2022 | $120 | -100.0% | 24,625 | +0.0% | 0.00% | -100.0% |
Q3 2022 | $355,000 | -4.6% | 24,615 | +0.2% | 0.00% | – |
Q2 2022 | $372,000 | +27.4% | 24,554 | -0.1% | 0.00% | – |
Q1 2022 | $292,000 | -92.4% | 24,579 | -89.6% | 0.00% | -100.0% |
Q4 2021 | $3,830,000 | -55.6% | 236,284 | -21.8% | 0.00% | -55.6% |
Q3 2021 | $8,619,000 | +5.5% | 301,998 | +24.9% | 0.01% | +12.5% |
Q2 2021 | $8,172,000 | +13.3% | 241,770 | +1.4% | 0.01% | 0.0% |
Q1 2021 | $7,213,000 | -27.0% | 238,527 | +19.5% | 0.01% | -27.3% |
Q4 2020 | $9,882,000 | +71.6% | 199,599 | +33.1% | 0.01% | +57.1% |
Q3 2020 | $5,758,000 | +5.1% | 149,980 | +18.3% | 0.01% | 0.0% |
Q2 2020 | $5,477,000 | +74.8% | 126,778 | +5.6% | 0.01% | +40.0% |
Q1 2020 | $3,134,000 | +382.2% | 120,078 | +477.3% | 0.01% | +400.0% |
Q4 2019 | $650,000 | +19.9% | 20,800 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $542,000 | +13.9% | 20,800 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $476,000 | +655.6% | 20,800 | +766.7% | 0.00% | – |
Q1 2019 | $63,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |